Phreesia Buys MediFind

Phreesia

Phreesia, a Wilmington, DE-based company which specializes in patient intake, outreach and activation, acquired Comsort, Inc. d/b/a MediFind, a Baltimore, MD- and Philadelphia, PA-based health technology company.

The amount of the deal was not disclosed.

With the acquisition, Phreesia will expand its offerings.

Led by CEO Patrick Howi, MediFind is a data science and consumer-centric health technology company, focusing on connecting patients with leading experts, clinical trials, health systems, and healthcare technologies through advanced analytics. The company uses machine learning and proprietary algorithms to continuously review medical information across a wide range of datasets, identifying leading doctors in specific conditions and fields based on factors such as their research output, volume of patients and standing among their peers. MediFind assigns four levels of expertise to those doctors: elite, distinguished, advanced and experienced.

Phreesia specializes in patient activation, giving providers, health plans, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022–more than 1 in 10 visits across the U.S.

FinSMEs

17/07/2023